<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Oct. 2, 2018 (HealthDay News) — Hyperbaric oxygen therapy (HBOT) added to standard medical therapy (MT) seems beneficial for sudden sensorineural hearing loss (SSNHL), according to a review published online Sept. 27 in JAMA Otolaryngology-Head & Neck Surgery<\/i>.<\/p>\n
Tae-Min Rhee, M.D., from the National Maritime Medical Research Center in Changwon, Korea, and colleagues conducted a systematic review and meta-analysis to compare HBOT + MT with MT alone for patients with SSNHL. Data were included from three randomized clinical trials and 16 nonrandomized studies, comparing outcomes in 2,401 patients with SSNHL.<\/p>\n
The researchers found that compared with the MT alone group, the HBOT + MT group had significantly higher pooled odds ratios for complete hearing recovery and any hearing recovery (odds ratios, 1.61 and 1.43, respectively). There was also a significantly greater absolute hearing gain in the HBOT + MT group versus the MT alone group. The benefit of HBOT was greater in groups with severe to profound hearing loss at baseline, HBOT as a salvage treatment, and a total HBOT duration of at least 1,200 minutes.<\/p>\n
“Optimal criteria for patient selection and a standardized regimen for HBOT should be applied in routine practice, with future trials to investigate maximal treatment benefit,” the authors write.<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n